Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Hizentra® in Inflammatory Neuropathies - pHeNIx Study
NCT04672733 | OBSERVATIONAL

The pHeNIx study, a national multicentre prospective non-interventional study, should help to describe the conditions of use for Hizentra® and the methods for switching from the IV to SC route in everyday practice, together with the tolerability and efficacy of treatment, which is monitored using a patient application (PRO: Patient-Reported Outcomes).

Trial Information
27 Sites
100 Participants
RECRUITING
18 Years

If interested, contact clinicaltrials@cslbehring.com or +1 610-878-4697 for more information

CSL Behring respects your privacy. For an explanation of how CSL Behring will use the information you are submitting, please view our Privacy Policy

SUBMIT
CHU Amiens Picardie
Amiens,France,80054
CHU Angers
Angers,France,80054
Hpital priv de La Casamance
Aubagne,France,80054
CH Bayonne
Bayonne,France,80054
Hpital Pellegrin
Bordeaux,France,80054
CHRU Brest
Brest,France,80054
Hpital Henri Mondor
Créteil,France,80054
Hpital Bictre
Le Kremlin-Bicêtre,France,80054
CH Libourne
Libourne,France,80054
Hpital Roger Salengro, CHU Lille
Lille,France,80054
Hpital Dupuytren
Limoges,France,80054
Hpital Pierre Wertheimer,HCL
Lyon,France,80054
Hpital de la Timone
Marseille,France,80054
CHU Montpellier
Montpellier,France,80054
CHRU Nancy
Nancy,France,80054
CHU Nantes
Nantes,France,80054
Hpital Pasteur
Nice,France,80054
Hpital Lariboisire
Paris,France,80054
La PitiSalptrire
Paris,France,80054
CHU Poitiers
Poitiers,France,86000
Centre hospitalier priv Saint Grgoire
Rennes,France,35760
Hpital Charles Nicolle
Rouen,France,35760
CHU SaintEtienne
Saint-Étienne,France,35760
CHU de Strasbourg
Strasbourg,France,67091
CHU Toulouse
Toulouse,France,67091
CHR Tours
Tours,France,67091
CH de Valence
Valence,France,26000

Study Eligibility Criteria

Additional Studies

Additional studies can be found at ClinicalTrials.gov